Education

Degree
PhD, UCLA School of Medicine, 2010
Fellowship
Gastroenterology, UCLA School of Medicine, 2008
Residency
Internal Medicine, Brigham & Women's Hospital, 2003
Internship
Internal Medicine, Brigham & Women's Hospital, 2002
Degree
MD, UC San Francisco School of Medicine, 2001

Medical Board Certifications

Gastroenterology
American Board of Internal Medicine, 2007

Gender

Male

State License

A83692
  • About Me

    About Me

    Academic Appointments
    • Assistant Professor of Medicine, David Geffen School of Medicine at UCLA

    Additional Education/Certification

    • PhD Cellular and Molecular Pathology, UCLA, 2010

    Links

  • Locations

    Pfleger Liver Institute

    (primary location)
    Address
    200 UCLA Medical Plaza
    Suite 214
    Los Angeles, California 90095
    Phone
    310-794-7788
  • Education

    Medical Board Certifications

    Gastroenterology
    American Board of Internal Medicine, 2007

    Education

    Degree
    PhD, UCLA School of Medicine, 2010
    Fellowship
    Gastroenterology, UCLA School of Medicine, 2008
    Residency
    Internal Medicine, Brigham & Women's Hospital, 2003
    Internship
    Internal Medicine, Brigham & Women's Hospital, 2002
    Degree
    MD, UC San Francisco School of Medicine, 2001
  • Clinical Interests
    • Celiac Disease
    • Familial Mediterranean Fever
    • Fatty Liver
    • General Gastroenterology
    • Hepatology
    • Liver Biopsy
    • Liver Transplantation
    • Malabsorption
  • Research

    Research Interest

    Hepatology, Metabolic Syndrome, Fatty liver, NAFLD, and NASH, Cholesterol and Fat Metabolism, Nuclear Receptors, Chronic viral hepatitis, Liver cancer, Liver fibrosis

    Publications

    • Beaven SW, Wroblewski K, Wang J, Hong C, Bensinger S, Tsukamoto H, Tontonoz P. " Liver X Receptor Signaling is a Determinant of Stellate Cell Activation and Susceptibility to Fibrotic Liver Disease." Gastroenterology. 2010 Dec 3. [Epub ahead of print]
    • Beaven SW & Tontonoz P. "Nuclear receptors in lipid metabolism: Targeting the heart of dyslipidemia." Annual Reviews of Medicine, 57:313-29. 2006.

    Link to my PubMed publications.

Simon Beaven, MD, PhD, click here to update your profile.